Drugs & Medical Devices
Get ready for the next wave of pharmaceutical litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.
SEARCH THE ARCHIVES
The judge overseeing the federal Tylenol multidistrict litigation has appointed Levin Fishbein Sedran & Berman’s Laurence S. Berman and Henry Spiegel Milling’s R. Clay Milling as plaintiff co-leads and liaison counsel.
The judge overseeing the federal pelvic repair system multidistrict litigation has denied C.R. Bard Inc.’s motion to seal certain of plaintiffs’ exhibits, finding Bard failed to establish that they contain confidential, proprietary information that would reveal its trade secrets to competitors.
Citing preservation of judicial resources, a California federal judge has stayed a NuvaRing injury case pending transfer to the federal multidistrict litigation, ruling that the MDL court should decide the plaintiff’s motion to remand.
McNeil PPC and its parent company Johnson & Johnson (NYSE: JNJ) seek consolidation of all New Jersey Tylenol liver injury cases in the Middlesex County (N.J.) Superior Court, asserting it would avoid duplicative discovery and inconsistent rulings.
A federal judge has granted Stryker Corp.’s (NYSE: SYK) motion to transfer a pain pump action to the U.S. District Court for the Western District of Virginia, explaining that a substantial part of the events giving rise to the alleged injury occurred in that district.
The Food Drug and Cosmetic Act preempts a class action accusing Johnson & Johnson (NYSE: JNJ) of misleading consumers as to the health benefits of its butter substitute spread because it seeks to impose stricter state law requirements for food labeling, a federal appeals court has ruled.
A federal judge in the U.S. District Court for the Eastern District of Missouri has adopted a position held by the majority of courts and ruled that removal of a Smith & Nephew hip defect case is premature when based on a federal question raised in the plaintiffs’ unresolved motion for leave to amend.
The plaintiff in a Zometa injury case may present evidence and argument at trial that Novartis Pharmaceuticals Corp. (NYSE: NVS) should have recommended a dosing regimen different than that approved by the Food and Drug Administration, a California federal judge has ruled, noting the drug maker could have made such recommendations without prior FDA approval.
A woman has sued Amylin Pharmaceuticals LLC and Eli Lilly and Co. (NYSE: LLY) in California federal court, accusing them of failing to warn doctors and the public that the type 2 diabetes drug Byetta can cause thyroid cancer.
Plaintiffs May Depose Exec as to C.R. Bard’s Alleged Use of Prohibited Resin in Pelvic Mesh Products
A West Virginia magistrate judge has reopened discovery in the C.R. Bard Inc. pelvic repair multidistrict litigation to allow plaintiffs to question a C.R. Bard executive as to the company’s alleged use of a prohibited raw polypropylene resin in its mesh products.